Results 71 to 80 of about 6,623 (181)

[Acellular pertussis vaccine].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 2008
Protective, immunogenic, toxic, and sensitizing properties of acellular pertussis vaccine (aPV) developed according to original technology were studied, aPV had marked protective activity which lasted more than 2 years. Sera of mice immunized by aPV also possess protective properties, and they were more prominent than in sera of mice immunized by ...
N S, Zakharova, M V, Britsina, N U, Mertsalova, I G, Bazhanova, M N, Ozeretskovskaia, E M, Zaĭtsev, A V, Poddubikov, B F, Semenov   +7 more
openaire   +1 more source

Maternal DTaP immunization and transplacental transfer of pertussis antibodies in Japan

International Journal of Infectious Diseases
Background: Maternal pertussis immunization prevents severe infection in early infancy. In Japan, the diphtheria–tetanus–acellular pertussis (DTaP) vaccine is available during pregnancy, whereas the tetanus–diphtheria–acellular pertussis (Tdap) vaccine ...
Kazuya Hiiragi, Ryosuke Shindo, Tomoyuki Kojima, Sayuri Nakanishi, Soichiro Obata, Etsuko Miyagi, Shigeru Aoki   +6 more
doaj   +1 more source

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine. [PDF]

J Infect Dis, 2022
Peterson JT, Zareba AM, Fitz-Patrick D, Essink BJ, Scott DA, Swanson KA, Chelani D, Radley D, Cooper D, Jansen KU, Dormitzer PR, Gruber WC, Gurtman A.   +12 more
europepmc   +1 more source

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. [PDF]

Front Immunol, 2023
Yount KS, Hall JM, Caution K, Shamseldin MM, Guo M, Marion K, Fullen AR, Huang Y, Maynard JA, Quataert SA, Deora R, Dubey P.   +11 more
europepmc   +1 more source

Revisiting Whooping Cough: Global Drivers and Implications of Pertussis Resurgence in the Acellular Vaccine Era

Vaccines
Background: Whooping cough caused by Bordetella pertussis is re-emerging despite high vaccination coverage, with rising incidence in adolescents and adults in the acellular vaccine (aP) era.
Siheng Zhang, Yan Xu, Ying Xiao
doaj   +1 more source

Acellular pertussis vaccine for adolescents [PDF]

Paediatrics & Child Health, 2003
openaire   +5 more sources

How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile? [PDF]

Hum Vaccin Immunother, 2021
Aguirre-Boza F, San Martín P P, Valenzuela B MT.   +2 more
europepmc   +1 more source

Poster Session 3

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Poster Session 1

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Impact of vaccination on epidemiology of diphtheria and pertussis

Vaccine Research, 2015
Whooping cough and diphtheria are vaccine preventable diseases. Diphtheria, due to Corynebacterium diphtheriae or Corynebactium ulcerans, two Gram positive bacteria, is a serious upper respiratory tract disease with high morbidity and mortality rates ...
N Guiso
doaj